Back to News
Apr 13, 2026 4:00 PM

ImageneBio $30 Million Private Placement Ignites Stock

ImageneBio Inc. (NASDAQ:IMA) shares are up on Monday following the announcement of a $30 million private placement aimed at advancing its therapeutic development.

ImageneBio is a clinical-stage biopharmaceutical company focused on developing therapeutics for immunological, autoimmune and inflammatory diseases.

• ImageneBio stock is surging to new heights today. What’s fueling IMA momentum?

Institutional Investors Back New Financing Deal

ImageneBio announced it has entered into a definitive securities purchase agreement with institutional investors, selling pre-funded warrants to purchase up to 5.77 million shares at $5.199 per warrant.

The company plans to use the proceeds ...